Colmenero, Jordi <br/><br/>
Effects of losartan on hepatic expression of nonphagocytic NADPH oxidase and fibrogenic genes in patients with chronic hepatitis C.  [electronic resource] 

 -  American journal of physiology. Gastrointestinal and liver physiology  Oct 2009 
 - G726-34 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase IV; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1522-1547 
<br/><br/><label>Standard No.: </label>10.1152/ajpgi.00162.2009  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adaptor Proteins, Signal Transducing<br/>Adaptor Proteins, Vesicular Transport--genetics<br/>Administration, Oral<br/>Angiotensin II Type 1 Receptor Blockers--administration & dosage<br/>Biopsy, Needle<br/>Collagen--genetics<br/>Down-Regulation<br/>Female<br/>Gene Expression Regulation, Enzymologic--drug effects<br/>Hepatitis C, Chronic--complications<br/>Humans<br/>Inflammation Mediators--metabolism<br/>Liver--drug effects<br/>Liver Cirrhosis--drug therapy<br/>Losartan--administration & dosage<br/>Male<br/>Matrix Metalloproteinase 2--genetics<br/>Middle Aged<br/>NADPH Oxidases--genetics<br/>Reverse Transcriptase Polymerase Chain Reaction<br/>Severity of Illness Index<br/>Spain<br/>Time Factors<br/>Treatment Outcome<br/>Urokinase-Type Plasminogen Activator--genetics<br/>rac1 GTP-Binding Protein--genetics